Registry following children who receive proton or photon radiation therapy
Collects health records of children treated with proton or photon radiation therapy.
Plain-language title generated from the registry record
Registry title: Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
Key facts
- Where
- Toronto, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for children and young people who are treated with radiation therapy at one of the taking-part centers. It collects information on their care.
- Age
- Younger than 22 years when radiation treatment starts (up to 21 Years).
- Sex
- All sexes can join.
- Disease stage
- No specific disease stage is required. Patients can join whatever other treatments they are having now or whatever the disease extent.
- Earlier treatment
- Previous local or systemic treatments do not matter. Patients can join whatever they received before.
Read by machine on 12 November 2026.
Where in Canada
- University Health Network, Princess Margaret HospitalToronto, CanadaContact: Derek Tsang, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Massachusetts General Hospital
- Trial code
- NCT01696721
- Record updated
- 5 October 2026
- Original description
In previous studies, Proton Beam Radiation Therapy (PBRT) has been found to show better results in treating patients with cancer, both because there is better control of where in the body the radiation is directed and because it is associated with less severe long term side effects. However, there is limited published data demonstrating these results. The goal of the Proton and Photon Consortium Registry (PPCR) is to enroll children treated with radiation in order to describe the population that currently receives radiation and better compare the short-term and long-term benefits of different types of radiotherapy. The data collected from this study will help facilitate research on radiation therapy and allow for collaborative research. The PPCR will collect demographic and clinical data that many centers that deliver radiation therapy already collect in routine operations.Read full original descriptionShow less
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
In previous studies, Proton Beam Radiation Therapy (PBRT) has been found to show better results in treating patients with cancer, both because there is better control of where in the body the radiation is directed and because it is associated with less severe long term side effects. However, there is limited published data demonstrating these results. The goal of the Proton and Photon Consortium Registry (PPCR) is to enroll children treated with radiation in order to describe the population that currently receives radiation and better compare the short-term and long-term benefits of different types of radiotherapy. The data collected from this study will help facilitate research on radiation therapy and allow for collaborative research. The PPCR will collect demographic and clinical data that many centers that deliver radiation therapy already collect in routine operations.
Eligibility Criteria:; Patients treated with radiation therapy at one of the participating centers; Age < 22 at time of treatment start; Patients may be enrolled regardless of previous local or systemic treatments received prior to enrollment in the PPCR; Patients may be enrolled regardless of other current local or systemic treatments or disease extent; Patients may be enrolled on the PPCR concurrently with another study or clinical trial.